Latest filing published 16 Jun 2020 for Endo International plc, €37k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Roger H. Kimmel span 4 companies, the busiest being Endo Pharmaceuticals Holdings Inc, Endo International plc and Schiff Nutrition International, Inc. We count 127 filings; the first trade dates from 4 January 2006 and the latest from 12 June 2020.
In open-market terms, that means 6 purchases worth €566k on one side and 20 sales worth €7.6M on the other. The net balance comes to €7.1M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 72 share grants and 26 option exercises.
The median purchase comes to €56k. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 16 June 2020, the filings show a share grant worth €37k in Endo International plc. The latest purchase dates back some time: it was published 3,334 days ago, on 6 September 2017. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 125 declarations